Aptar Pharma and Dianosic Forge Exclusive Partnership to Advance Resorbable Intranasal Scaffold Technology for Chronic Rhinitis, Sinusitis, and Beyond In a strategic move that underscores the growing importance of patient-centric intranasal drug delivery platforms, Aptar Pharma, a global leader in…
WHO Expands Essential Medicines Lists to Include Landmark Treatments for Cancer, Diabetes, and Other Major Disease The World Health Organization (WHO) has announced a major update to its Model Lists of Essential Medicines (EML) and the Essential Medicines for Children…
Gilead Partners With PEPFAR and Global Fund to Deliver Twice-Yearly Lenacapavir for HIV Prevention Across Low- and Lower-Middle-Income Countries Gilead Sciences, Inc. (Nasdaq: GILD) has announced a major new global partnership with the U.S. State Department, the United States President’s…
MRM Health Secures €55 Million Series B Financing to Accelerate Development of Best-in-Class Microbiome-Based Biotherapeutics MRM Health NV, a pioneering clinical-stage biopharmaceutical company developing transformative microbiome-based therapeutics, announced the successful closing of a €55 million (approximately US$64 million) Series B…
MEDIPAL Holdings and JCR Pharmaceuticals Expand Rare Disease Collaboration with Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Investigational Therapy for GM2 Gangliosidosis In a significant advancement for patients and families affected by ultra-rare lysosomal storage disorders, MEDIPAL…
Neurotech Pharmaceuticals Strengthens Leadership with Appointment of Dr. Peter J. McDonnell to Board of Directors Neurotech Pharmaceuticals, Inc., a privately held biotechnology company pioneering transformative therapies for chronic eye diseases, today announced the appointment of Peter J. McDonnell, M.D., a…
Enlaza Therapeutics and Vertex Pharmaceuticals Forge Multi-Billion-Dollar Collaboration to Advance Next-Generation Covalent Biologics in Autoimmune Diseases and Conditioning Therapies Enlaza Therapeutics (“Enlaza” or the “Company”), a pioneering biotechnology firm and the first company to build a dedicated covalent biologics platform,…
Daiichi Sankyo Advances Cardiovascular Care with Development of Oral Triple Combination Lipid-Lowering Tablets A New Chapter in Cholesterol Management Daiichi Sankyo Europe has unveiled an ambitious new initiative: the development of innovative oral triple combination tablets designed to help patients…
Bristol Myers Squibb Showcases Landmark Real-World Data on Camzyos in Obstructive Hypertrophic Cardiomyopathy at ESC Congress 2025 Bristol Myers Squibb (NYSE: BMY) unveiled new results from its global COLLIGO-HCM study at the European Society of Cardiology (ESC) Congress 2025 in…
James F. Young, Ph.D. Appointed Executive Chairman of TechImmune, Bringing Four Decades of Vaccine Innovation and Leadership to the Fight Against Long COVID TechImmune, a biotechnology company at the forefront of immune-driven therapies for Long COVID and related conditions, has…
Thermo Fisher Scientific Honored with Three R&D 100 Awards for Innovations Transforming Precision Medicine, Cell Therapy, and Biopharmaceutical Research Thermo Fisher Scientific Inc. (NYSE: TMO), the global leader in serving science, has once again demonstrated its commitment to advancing the…
Tasso and SheMed Partner to Deliver At-Home Blood Testing for Safer, Personalized GLP-1 Treatments in the UK In a move that could transform how women access and experience weight loss treatments, Tasso, Inc., a U.S.-based leader in patient-centric blood collection…
